Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone Fixed-dose Study in MDD
NCT01473381Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vilazodone in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Dec 2011; status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01473381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473381.